SOHO Global Health, headquartered in Indonesia, is a prominent player in the pharmaceutical and healthcare industry, specialising in the development and distribution of high-quality medicines and healthcare products. Founded in 2012, the company has rapidly expanded its operations across Southeast Asia, establishing a strong presence in key markets. With a focus on innovative healthcare solutions, SOHO Global Health offers a diverse range of products, including prescription medications, over-the-counter drugs, and nutritional supplements. Their commitment to quality and sustainability sets them apart in a competitive landscape. Recognised for their excellence, the company has achieved significant milestones, including various certifications and partnerships that enhance their market position. As a trusted name in healthcare, SOHO Global Health continues to contribute to the well-being of communities throughout the region.
How does SOHO Global Health's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
SOHO Global Health's score of 16 is lower than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2022, SOHO Global Health, headquartered in Indonesia, reported total carbon emissions of approximately 7,810,840 kg CO2e. This figure includes Scope 1 emissions of about 3,580 kg CO2e, primarily from mobile combustion, and Scope 2 emissions of approximately 7,060,770 kg CO2e, attributed to purchased electricity. Additionally, Scope 3 emissions totalled around 691,430 kg CO2e, with significant contributions from upstream transportation and distribution, as well as waste generated in operations. Comparatively, in 2021, the organisation's total emissions were about 8,109,070 kg CO2e, indicating a slight reduction in emissions year-on-year. The breakdown for 2021 included Scope 1 emissions of approximately 3,020 kg CO2e, Scope 2 emissions of about 7,277,260 kg CO2e, and Scope 3 emissions of around 686,610 kg CO2e. Despite these figures, SOHO Global Health has not publicly committed to specific reduction targets or initiatives, as indicated by the absence of SBTi (Science Based Targets initiative) reduction targets or documented climate pledges. The emissions data is sourced directly from PT Soho Global Health Tbk, with no cascading from a parent organisation. Overall, while SOHO Global Health has made progress in managing its carbon footprint, further commitments and strategies may be necessary to enhance its sustainability efforts in the future.
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | |
|---|---|---|---|
| Scope 1 | 821,950 | 000,000 | 000,000 |
| Scope 2 | 8,469,260 | 0,000,000 | 0,000,000 |
| Scope 3 | 228,930 | 000,000 | 000,000 |
SOHO Global Health's Scope 3 emissions, which increased by 7% last year and increased by approximately 14% since 2019, demonstrating supply chain emissions tracking. Their carbon footprint includes suppliers and value chain emissions, with Scope 3 emissions accounting for 3% of total emissions under the GHG Protocol, with "Fuel and Energy Related Activities" being the largest emissions source at 98% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
SOHO Global Health has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
